Skip to main content
Glama

Monday

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. Changed3 schema fields changed
    • changedInput schema / properties / type / description
      Previous value: -"Entity type. v1 supports \"company\"."New value: +"Entity type: \"company\" or \"drug\"."
    • changedInput schema / properties / type / enum
      Previous value: -[
-  "company"
-]New value: +[
+  "company",
+  "drug"
+]
    • changedInput schema / properties / value / description
      Previous value: -"Ticker, CIK, or company name (e.g., \"AAPL\", \"0000320193\", \"Apple\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."
  3. Added

TDQS

A4.2/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnly, openWorld, idempotent, and non-destructive. The description goes well beyond them by disclosing failure behavior ('LEI/FIGI enrichment degrades gracefully'), ambiguity handling ('asserts nothing and returns figi_candidates'), unresolved identifier handling ('stated explicitly under unresolved'), and internal cascading ('replaces 2-3 manual lookups').

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with user intents and a clear directive, but it is sprawling and dense. The 'company' branch is a single long run-on sentence packed with parentheticals and multiple overlapping clauses. The content is relevant, but structuring it with bullets or shorter sentences would significantly improve scannability.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

There is no output schema, so the description carries the burden of explaining return behavior. It does this thoroughly: identifiers are labelled with source, unresolved identifiers are listed, ambiguity yields figi_candidates, drug lookups return RxCUI+ingredient+brand and a citation. Success, partial-failure, and ambiguity cases are all covered.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% and the schema already contains detailed descriptions and the ENTITY NAME ONLY warning. The description adds value with concrete examples ('AAPL', 'CH0038863350'), the distinction between issuer vs instrument names, and the non-equity edge case. This reinforces and slightly extends schema semantics.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose4/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the core function: resolving a user-spoken NAME to canonical/official identifiers, with specific outputs for each type (CIK, LEI, FIGI, RxCUI). It distinguishes itself as the ID-resolution utility by saying 'other tools require as input.' However, it does not explicitly name any sibling tool to draw the boundary, so differentiation is implied rather than explicit.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description gives a strong trigger condition: 'Use FIRST whenever you have a name but need an ID.' It also provides practical guidance on how to pass issuer names for instruments and warns about trailing security-class words. It stops short of saying when NOT to use the tool or naming alternatives, so exclusions are missing.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Monday toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

The set has several overlapping tool clusters. ask_pipeworx and ask_pipeworx_beta are explicitly identical in behavior, ai_visibility_check and scan_competitor_ai_presence overlap heavily, and polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, and polymarket_fill_risk all target opportunity-finding/fill-checking on prediction markets. While individual descriptions are detailed, an agent could easily pick the wrong tool among these near-duplicates.

Naming Consistency2/5

Naming is inconsistent across the surface. The monday_* and polymarket_* prefixes are consistent within their subgroups, and ask_pipeworx_* forms a family, but the rest mix verb_phrase (validate_claim, compare_entities, discover_tools), noun_phrase (entity_profile, recent_changes, suggest_questions), and bare verbs (remember, forget, recall) with no unifying pattern. This makes it hard to predict tool names.

Tool Count2/5

At 36 tools, the surface is overloaded. The Monday.com integration alone only needs 5 tools, and the remaining 31 are a sprawling research/meta-toolkit. Many of these could be consolidated (e.g., ask_pipeworx and ask_pipeworx_beta, or the several polymarket scanners), so the count feels inflated beyond what the server's core purpose requires.

Completeness3/5

The data-research and monitoring side is thorough, covering querying, grounding, comparison, profiling, entity resolution, subscriptions, memory, and feedback. However, the Monday.com integration is incomplete: it offers create/list/get/search for items but no update or delete operations, and no board creation or modification. This leaves the Monday workflow with dead ends.

Resources